Company Focus
Bristol Myers Squibb
Latest Bristol Myers Squibb News
Biotechnology
Bristol Myers Squibb has received a new approval from the US Food and Drug Administration for its blockbuster checkpoint blocker, Opdivo (nivolumab). 4 October 2024
Related News
Insights
Company Spotlight
A clinical-stage biotech company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders.
Latest News & Features of interest to Bristol Myers Squibb
Biotechnology
US oncology focused biotech Syros Pharmaceuticals announced that it will discontinue enrollment in the SELECT-AML-1 Phase II clinical trial. 14 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Pharmaceutical
The shortage of drugs in Russia is deepening, and is currently being observed in almost 70 regions throughout the country and forcing the local state to consider ways to resume stable supplies to local market, reports The Pharma Letter’s local correspondent. 13 August 2024
Biotechnology
CRISPR genome-editing biopharma company Caribou Biosciences has announced the appointment of Tina Albertson as chief medical officer (CMO). 13 August 2024
Biotechnology
Daiichi Sankyo’s shares rose 5.5% to 5,758 yen this morning, after it announced a third approval in China for Enhertu (trastuzumab deruxtecan). 13 August 2024
Biotechnology
Octapharma announced the results from the Phase III (LEX-209) study on the efficacy and safety of Balfaxar (prothrombin complex concentrate, human-lans) have been published by the American peer-reviewed journal JAMA Network Open. 13 August 2024
Biotechnology
Shares in Actinogen Medical, an Australian biotech developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol, closed 58% lower on Monday. 13 August 2024
Biotechnology
Connecticut, USA-based biotech start-up Halda Therapeutics announced that it has raised new financing of $126 million in a Series B extension. 13 August 2024
Biotechnology
German drug discovery company Evotec has announced the latest progress of its strategic partnership with US pharma major Bristol Myers Squibb relating to building a molecular glue-based pipeline. 13 August 2024
Biotechnology
Australian biotech CSL Limited today reported revenue of A$14.8 billion (US$9.7 billion) for the 12 months ended June 30, 2024. 13 August 2024
Latest In Brief for Bristol Myers Squibb
Biotechnology
Sirnaomics, a firm specializing in RNAi therapeutics, has entered into a subscription agreement with biotech specialist Poon Hung Fai. 4 October 2024
Latest Relevant Ones To Watch News
US clinical-stage biotech OnKure Therapeutics has announced the completion of its previously announced merger with Reneo Pharmaceuticals. 8 October 2024
24 September 2024
24 September 2024
19 September 2024
16 September 2024
Relevant Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze